Who invested in Eupraxia Pharmaceuticals

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 9 months ago

Funding summaryUpdated 26 Oct 2026

$64Mraised across 2 rounds since 2012, from 2 sources

$377KSeed$63MRound

Latest round: Round, $63MFeb 2026
Step-upi: 167.7×
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2014201620182020202220242026

$377KSeed$63MRound

First round: Seed, $377K
Biggest round: $63M
Between rounds: 13.1 years

The rounds

Feb 2026
Round$63M1 new
- SVB Capital
Source recorded
Dec 2012
Seed$377K
No investor was named in the report.
Reported by sec.gov

Founders and team

From Eupraxia Pharmaceuticals's own website: 14 on the team.

James A. HelliwellChief Executive Officer and Director
Alex TherienExecutive Vice President, Research & Development
Jeff MillardExecutive Vice President, Technical Operations
Wajida LeclercExecutive Vice President, Corporate Services & People
Alex RothwellChief Financial Officer
Dr. Jeymi TambiahChief Medical Officer
Paul BrennanChief Corporate Development Officer
Amy PottDirector
Helen ThackrayDirector
John MontalbanoDirector
Joseph FreedmanDirector
Richard GlickmanDirector
Robert BazemoreDirector
Simon PimstoneChairman of the Board

AdvisersDr. Albert J BredenoordDr. Donna GriebelDr. Evan DellonDr. Nirmala GonsalvesDr. Roos PouwDr. Stephen Attwood

Everyone who backed them

SVB CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Eupraxia Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.